• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
trans-Retinoic Acid

trans-Retinoic Acid

Product ID R1780
Cas No. 302-79-4
Purity ≥98%
Product Unit SizeCostQuantityStock
500 mg $85.20 In stock
1 g $141.80 In stock
5 g $425.70 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Trans-retinoic acid (RA) is an activator of the retinoic acid receptor (RAR) that exhibits anti-fibrotic, antiviral, antibacterial, immunomodulatory, and anticancer chemotherapeutic activities. RA is a vitamin A carboxylic acid that is clinically used to treat acne vulgaris, keratosis pilaris, and acute promyelocytic leukemia (APL). In vivo, RA inhibits fibroblast proliferation and scar formation and decreases levels of TGF-β1, IL-6, and NF-κB. This compound also induces expression of IFNα in cells infected with enterovirus 71, decreasing viral infectivity. In subjects with APL, retinoic acid forces promyelocytes to differentiate into normal blood cells. In cutaneous squamous cell carcinoma cells, RA induces G1 phase cell cycle arrest, increases expression of p21 and p27, decreases expression of cyclin D1/CDK4 and cyclin E/CDK2, and induces apoptosis. RA decreases cellular cholesterol and inhibits Mycobacterium in an NPC2-dependent manner. This compound also induces expression of hedgehog (Hh) signaling receptor Patched 1, inhibiting Hh signaling.

Product Info

Cas No.

302-79-4

Purity

≥98%

Formula

C20H28O2

Formula Wt.

300.44

Chemical Name

(all-E)-3,7-Dimethyl-9-(2,6,6-trimethyl- 1-cyclo-hexen- 1-yl)-2,4,6,8-nonatetraenoic acid

IUPAC Name

(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6, 8-tetraenoic acid

Synonym

Retinoic acid, Vitamin A acid, tretinoin, Aberel, Avita, Eudyna, Kerlocal, Renova, Retin-A, Vesanoid

Melting Point

180-182°C

Solubility

Soluble in DMSO. Slightly soluble in polyethylene glycol, octanol or ethanol. Practically insoluble in water, mineral oil or glycerin.

Appearance

Yellow/slight orange crystal powder

Shipping and Storage

Store Temp

-20°C

Ship Temp

Ambient

Downloads

MSDS

R1780 MSDS PDF

Info Sheet

R1780 Info Sheet PDF

References

Chen S, Yang Y, Xu J, et al. Effect of all-trans-retinoic acid on enterovirus 71 infection in vitro. Br J Nutr. 2014 May;111(9):1586-93. PMID: 24495389.

Zhang ML, Tao Y, Zhou WQ, et al. All-trans retinoic acid induces cell-cycle arrest in human cutaneous squamous carcinoma cells by inhibiting the mitogen-activated protein kinase-activated protein 1 pathway. Clin Exp Dermatol. 2014 Apr;39(3):354-60. PMID: 24635079.

Busch AM, Galimberti F, Nehls KE, et al. All-trans-retinoic acid antagonizes the Hedgehog pathway by inducing patched. Cancer Biol Ther. 2014 Apr;15(4):463-72. PMID: 24496080.

Zhang C, Kong X, Ning G, et al. All-trans retinoic acid prevents epidural fibrosis through NF-κB signaling pathway in post-laminectomy rats. Neuropharmacology. 2014 Apr;79:275-81. PMID: 24316159.

Wheelwright M, Kim EW, Inkeles MS, et al. All-trans retinoic acid-triggered antimicrobial activity against Mycobacterium tuberculosis is dependent on NPC2. J Immunol. 2014 Mar 1;192(5):2280-90. PMID: 24501203.

Zhu YF, Hu JZ, Zhao PN, et al. All-transretinoic acid regulates Th1/Th2 balance in CD4+ T cells when GATA-3 is deficient. Biomed Environ Sci. 2013 Sep;26(9):774-7. PMID: 24099613.

Chomienne C, Ballerini P, Balitrand N, et al. All-trans retinoic acid in acute promyelocytic leukemias. II. In vitro studies: structure-function relationship. Blood. 1990 Nov 1;76(9):1710-7. PMID: 2224120.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • T6903

    Tranylcypromine Hydrochloride

    MAO and histone demethylase LSD1 inhibitor.

    ≥98%
  • M2408

    MGCD-265 Analog

    MET inhibitor.

    ≥98%
  • S8345

    S-(−)-Sulpiride

    GHB agonist, D2/3 antagonist.

    ≥99%
  • I5357

    Inositol

    Endogenous sugar produced from glucose, require...

    ≥98%
  • K1978

    Ketorolac Tromethamine

    NSAID; COX-1/2 inhibitor.

    ≥98%
  • E0813

    Ecdysterone

    Natural steroid hormone produced by arthropods;...

    ≥96%
  • S0253

    Sanguinarine

    Benzophenanthridine alkaloid found in various p...

    ≥98%
  • E7858

    Etoricoxib

    NSAID; COX-2 inhibitor.

    ≥99%
  • N5768

    Norfloxacin

    Fluoroquinolone; topoisomerase IV and bacterial...

    ≥98%
  • C5662

    Copper Bis-3,5-diisopropylsalicylate

    Antioxidant.

    ≥97%
  • C5771

    Corticosterone

    Endogenous steroid hormone involved in immune r...

    ≥98%
  • G4634

    Glipizide

    Sulfonylurea; ATP-sensitive K+ channel blocker....

    ≥98%
  • C9882

    Cytochalasin E

    Mycotoxin produced by Aspergillus; actin polyme...

    ≥98%
  • I7457

    1-Isothiocyanato-6-(methylsulfinyl)-hexane

    Synthetic derivative of 6-methylsulfinyl-hexane...

    ≥98%
  • C4517

    Clenbuterol Hydrochloride

    β2-adrenergic agonist.

    ≥98%
  • P0109

    P7C3A20

    Fluorinated aminopropyl carbazole, neuroprotect...

    ≥94%
  • T8006

    Tubastatin A Hydrochloride

    HDAC6/10 inhibitor.

    ≥98%
  • G733404

    GSK3685032

    Reversible DNMT1-selective inhibitor

    ≥98%
  • L0251

    Laminin Peptide CDPGYIGSR

    Laminin-derived nonapeptide.

    ≥98%
  • M7200

    MS436

    BRD4 inhibitor.

    ≥99%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only